Bethesda, MD, United States of America

Neville Kisalu

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Sanaria Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neville Kisalu. Retrieved from https://idiyas.com/inventor/neville-kisalu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Neville Kisalu

Introduction

Neville Kisalu, an accomplished inventor based in Bethesda, MD, has made significant strides in the field of biomedicine. With a remarkable portfolio of two patents, Kisalu has demonstrated his commitment to advancing healthcare solutions, particularly in the fight against malaria.

Latest Patents

Kisalu's most recent patents focus on groundbreaking developments in therapeutic antibodies. His work on "Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use" introduces antibodies and antigen binding fragments that specifically target and neutralize the circumsporozoite protein, a crucial component in the malaria parasite’s lifecycle. The technologies outlined in these patents also encompass nucleic acids encoding these antibodies, along with associated vectors and host cells. The applications of these innovations hold promise for inhibiting malaria infections, a significant health concern worldwide.

Career Highlights

Throughout his career, Neville Kisalu has been affiliated with notable organizations, enhancing his research impact. He has worked with the United States of America as represented by the Secretary of the Department of Health and Human Services, as well as Sanaria Inc., a company dedicated to developing new vaccines against malaria. His work reflects his dedication to scientific innovation and public health.

Collaborations

Kisalu's collaboration with esteemed colleagues such as Robert Seder and Azza Idris underscores the collaborative spirit of research in the healthcare sector. Together, they have worked towards creating effective interventions against malaria, contributing to the collective goal of improving global health outcomes.

Conclusion

Neville Kisalu continues to be a pivotal figure in the realm of biomedicine, with his patents poised to influence the future of malaria treatment significantly. His innovations highlight the importance of dedication and collaboration in tackling some of the world’s most pressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…